We're your partner
When R&D gets slow and complex in your T-cell drug discovery program and you need complete binding kinetic data of thousands of molecular interactions in short time, BioCopy is your partner. We are globally leading for speed and throughput in molecular interaction analysis.
At BioCopy, we make lead finding and characterization in your R&D program for T-cell therapy drug discovery highly efficient. With our technology and expertise, we simultaneously analyze interactions of TCR, bi- and multispecifics, and other biomolecules for binding against thousands of peptide-HLA complexes. Our proprietary microarray system investigates up to 5,000 interactions with peptide-HLA in parallel, within a single measurement, and including the analysis of binding kinetics. This enables the identification of lead candidates from highly complex libraries, comprising thousands of tumor and other disease-specific antigens for future treatments in oncology and autoimmune diseases.
BioCopy provides you with complete data sets within days, saving months of R&D time as well as large amounts of R&D specimen compared to other techniques, such as Biolayer Interferometry (BLI) or Surface Plasmon Resonance (SPR).